tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market

Cyclerion Therapeutics (CYCN) Income Statement

Compare
237 Followers

Cyclerion Therapeutics Income Statement

Last quarter (Q3 2024), Cyclerion Therapeutics's total revenue was $194.00K, an increase of Infinity% from the same quarter last year. In Q3, Cyclerion Therapeutics's net income was $-723.00K. See Cyclerion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 297.00K$ 3.32M$ 2.30M$ 4.51M
Gross Profit
$ 0.00$ 232.00K$ 2.85M$ 2.30M$ 4.51M
Operating Expenses
$ 9.65M$ 44.67M$ 57.63M$ 85.23M$ 129.54M
Depreciation and Amortization
$ -2.95M$ 65.00K$ 472.00K$ 2.30M$ 2.70M
EBITDA
$ -12.59M$ -18.18M$ -55.20M$ -81.27M$ -122.34M
Operating Income
$ -9.65M$ -44.37M$ -55.20M$ -81.27M$ -125.04M
Other Income/Expenses
$ -2.95M$ 294.00K$ 3.55M$ 3.46M$ 2.03M
Pretax Income
$ -12.59M$ -44.08M$ -51.65M$ -77.80M$ -123.01M
Net Income
$ -21.02M$ -43.78M$ -51.66M$ -72.67M$ -120.98M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.99$ -20.15$ -26.40$ -47.80$ -88.37
Diluted EPS
$ -8.99$ -20.15$ -26.40$ -47.80$ -88.37
Weighted Average Shares Outstanding
2.34M 2.17M 1.96M 1.52M 1.37M
Weighted Average Shares Outstanding (Diluted)
2.34M 2.17M 1.96M 1.52M 1.37M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis